You searched for "therapeutics"
Moorfeilds: TED series - Motility and quality of life
8 July 2025
TED seriesNational meeting series on thyroid eye diseaseThe Adnexal Team at Moorfields Eye Hospital are pleased to present TED series, an ongoing series of FREE, evening hybrid meetings covering key aspects of thyroid eye disease. The aim of the meetings...
Corporate M&A pace gathers momentum
1 October 2019
| Rod McNeil
|
EYE - General
Intensifying franchise competition, maturing product development pipelines and looming loss of exclusivity spur renewed merger and acquisition (M&A) activity in the ophthalmics sector. Rod McNeil reviews recent deals and related strategic developments. AbbVie to acquire Allergan in $63 billion mega-combination,...
How the thinking machine is transforming the retinal landscape
1 May 2025
| Zhihang Cheng
|
EYE - Vitreo-Retinal
Regulatory approval of the first two therapeutic substances for the management of geographic atrophy (GA) secondary to age-related macular degeneration has been a major breakthrough. The authors explored the issue surrounding the lack of agreed therapeutic standards and diagnostic tools...
Therapeutic ocular surface medium for persistent corneal epithelial defect
Corneal ulcers and persistent epithelial defects (PEDs) are caused by a variety of different insults to the cornea, which includes limbal epithelial stem cell failure. PED may be resistant to healing with standard therapy such as frequent ointments and /...Congratulations to the SOC poster prize winners!
24 September 2021
The Scottish Ophthalmological Club (SOC) recently hosted another excellent webinar on the theme ‘Post COVID – The Best of Times and The Worst of Times'.
Early bird bookings are open for Optometry Tomorrow 2024 – now incorporating BCLA Focus
Taking place from 28-29 April 2024, at the Telford International Centre, the flagship conference of The College of Optometrists now incorporates the biennial UK conference of the British Contact Lens Association.Retina UK Annual Conference 2025
20 September 2025
The Retina UK Conference is an excellent opportunity to find out the latest news from Retina UK, hear from expert speakers, meet other members of our community and to make new connections. The line-up for their 50th anniversary year conference...
Regulatory drug evaluations and expedited review initiatives: EU and US perspectives
1 April 2016
| Rod McNeil
|
EYE - General
The European Medicines Agency (EMA) and United States Food and Drug Administration (FDA) each conduct independent assessments of benefit-risk profile when evaluating applications to market new or modified medicines, and their respective decision-making is guided by distinct legislation, procedures and...
New study uncovers key mechanism behind a common genetic cause of age-related visual loss
19 September 2024
|
Cornea / External Eye Disease
|
endothelial cells, age, vision loss, research, academic, new, genetics, genome, Fuchs Endothelial Corneal Dystrophy, FECD
A groundbreaking study has revealed important insights into the mechanisms behind Fuchs Endothelial Corneal Dystrophy (FECD), a common cause of age-related visual loss, providing hope for future therapeutic developments, and finding implications for other neurological diseases. FECD is a common,...
Worshipful Company of Spectacle Makers awards silver medal to Professor Robert Maclaren
At a Court Lunch held in the historic Apothecaries’ Hall last week, the Worshipful Company of Spectacle Makers awarded its prestigious Silver (Fincham) Medal to Professor Robert MacLaren. Professor MacLaren is Professor of Ophthalmology at the University of Oxford, Consultant...Amblyopia treatment review
This review paper summarises the main causes and neural mechanisms that characterise amblyopia. The authors analysed neuroanatomical, neurophysiological and electrophysiological studies in the literature to better understand actual treatment regimens and evaluate new therapeutic possibilities. They considered causes of strabismus,...Developments in Ophthalmology: Ophthalmic Radiation Therapy Techniques and Applications
1 February 2015
| Sofia Rokerya
|
EYE - Paediatrics, EYE - Strabismus, EYE - General, EYE - Neuro-ophthalmology
Radiation was discovered by Wilhelm Roentgen in 1895, and since then has been used to treat a variety of cancers. Its therapeutic properties have been widely used for ocular and periocular tumours and inflammatory disease, but the present era is...